| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $108.4M | — | +83.8% |
| Cost of Revenue | $29.3M | — | +39.5% |
| Gross Profit | $79.1M | — | +108.3% |
| R&D Expense | $14.7M | — | +40.9% |
| SG&A Expense | $46.6M | — | +56.0% |
| Operating Income | $17.8M | — | +870.4% |
| Pre-tax Income | $18.5M | — | +576.1% |
| Income Tax | $539K | — | +439.0% |
| Net Income | $18.0M | — | +550.6% |
| EPS (Basic) | $0.39 | — | +200.0% |
| EPS (Diluted) | $0.34 | — | +187.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $537.5M | +8.4% | — |
| Accounts Receivable | $61.3M | +47.3% | — |
| Inventory | $19.2M | +9.5% | — |
| Current Assets | $624.1M | +11.3% | — |
| Total Assets | $700.7M | +10.8% | — |
| Current Liabilities | $57.2M | +19.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $15.4M | — | +487.8% |
| Capital Expenditures | $4.5M | — | +90.5% |
| Investing Cash Flow | -$4.5M | — | -90.5% |
| Financing Cash Flow | $30.5M | — | — |
| Free Cash Flow | $11.0M | — | +3842.1% |
| Long-term Debt | $90.0M | +57.3% | — |
| Total Liabilities | $195.1M | +27.9% | — |
| Stockholders' Equity | $505.6M | +5.3% | +299.9% |